However, in breast cancer cells, FRK suppresses cell proliferation by arresting cells in the G1 phase of the cell cycle [5, 13]; regulating PTEN protein stability and function [8]; inhibiting EGFR signaling [14], and by regulating the stability and potentially the tumor suppressor function of BRCA1 protein [15]. Here, FRK is linked to breast carcinoma.